Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients

被引:0
作者
Annelies B. Blanken
Reinder Raadsen
Rabia Agca
Alper M. van Sijl
Yvo M. Smulders
Michael T. Nurmohamed
机构
[1] Amsterdam Rheumatology and Immunology Center,Amsterdam Rheumatology and Immunology Center, Location Amsterdam UMC, Department of Rheumatology
[2] Location Reade,Amsterdam UMC, Department of Internal Medicine
[3] Department of Rheumatology,undefined
[4] VU University Medical Center,undefined
[5] VU University Medical Center,undefined
来源
Rheumatology International | 2023年 / 43卷
关键词
Rheumatoid arthritis; Atherosclerosis; Intima-media thickness; Pulse wave velocity; Arterial stiffness; Anti-inflammatory therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:315 / 322
页数:7
相关论文
共 147 条
[1]  
Agca R(2016)Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders Heart 102 790-795
[2]  
Heslinga SC(2009)Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study Arth Rheum 61 1571-1579
[3]  
van Halm VP(2009)Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation Ann Rheum Dis 68 1395-1400
[4]  
Nurmohamed MT(2003)Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2957-2963
[5]  
Peters MJ(2008)Role of inflammation in atherosclerosis associated with rheumatoid arthritis Am J Med 121 S21-31
[6]  
van Halm VP(2014)Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology 53 1108-1119
[7]  
Voskuyl AE(2013)Certolizumab pegol attenuates the pro-inflammatory state in endothelial cells in a manner that is atheroprotective Clin Exp Rheumatol 31 225-233
[8]  
Smulders YM(2006)Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study Arthritis Res Ther 8 R151-1218
[9]  
Boers M(2005)Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis J Rheumatol 32 1213-2942
[10]  
Lems WF(2006)Vascular biomarkers and surrogates in cardiovascular disease Circulation 113 2936-2190